FDA has recently approved two groundbreaking treatments, Casgevy and Lyfgenia, which characterize the cell-based gene therapies for treating sickle cell diseases in individuals 12 years and older. Casegevy was the first approved treatment to use...

Research and drug development is a complex, multifaceted process. On average, it takes at least 10 years for a new medicine to complete the journey from initial discovery to the marketplace.